Biosimilars Will Foster Competition and Lower Costs

Last week, over 450 health and technology leaders convened in a packed DC conference center for a morning summit on the present and future of Artificial Intelligence (AI) hosted by the DC Tech & Venture Coalition (DCTAV), a coalition of executives, entrepreneurs, and investors dedicated to improving the District of Columbia’s role as a hub of technology and capital.

AMCP member advocates from across the country took to Capitol Hill to speak with lawmakers about ways to improve patient access to innovative new treatments as well as critical pharmacy legislation.

Key takeaways from AMCP’s recent AI Preconference in Houston, Texas, where leaders in pharmacy, healthcare, technology, and policy gathered for a half-day of deep, engaging discussions at AMCP 2025.